Table 7 Stratified analysis of LINC02122 polymorphism rs10036719 and prognosis of GC
From: lncRNA polymorphism affects the prognosis of gastric cancer
rs10036719 | ≦65 | >65 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Stages I–III | Stage IV | Stages I–III | Stage IV | |||||||||
N | MST (M) | HR (95% CI) | N | MST (M) | HR (95% CI) | N | MST (M) | HR (95% CI) | N | MST (M) | HR (95% CI) | |
Codominance | ||||||||||||
 GG | 13 | 73.00 | 1 | 4 | 6.00 | 1 | 17 | 33.00 | 1 | 11 | 8.00 | 1 |
 AG | 38 | 105.24 | 1.206 (0.384–3.783) | 13 | 10.00 | 0.720 (0.202–2.560) | 61 | 81.00 | 0.592 (0.279–1.256) | 43 | 9.00 | 0.935 (0.457–1.914) |
 AA | 39 | 72.25 | 1.206 (0.387–3.752) | 13 | 19.00 | 0.554 (0.148–2.081) | 49 | 115.44 | 0.377 (0.165–0.859) | 43 | 10.00 | 0.676 (0.333–1.374) |
Dominant model | ||||||||||||
 GG | 13 | 73.00 | 1 | 4 | 6.00 | 1 | 17 | 33.00 | 1 | 11 | 8.00 | 1 |
 AG+AA | 77 | 101.82 | 1.206 (0.414–3.512) | 26 | 12.00 | 0.643 (0.189–2.181) | 110 | 147.15 | 0.490 (0.241–0.997) | 86 | 9.00 | 0.780 (0.398–1.530) |
Recessive model | ||||||||||||
 GG+AG | 51 | 96.94 | 1 | 17 | 10.00 | 1 | 78 | 75.00 | 1 | 54 | 8.00 | 1 |
 AA | 39 | 72.25 | 1.050 (0.503–2.192) | 13 | 19.00 | 0.727 (0.317–1.668) | 49 | 115.44 | 0.562 (0.302–1.046) | 43 | 10.00 | 0.713 (0.461–1.100) |